Concepedia

John J. Kavanagh

JJ

Statistics

Publications

7

Citations

256

H-Index

7

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anderson Hospital

John J. Kavanagh is an author at The University of Texas MD Anderson Cancer Center specializing in chemotherapy, oncology, and medicine.

Publications per year

1991–2001

7

Publications

7

A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer

Claire F. Verschraegen, Elora Gupta, Evelyne M. Loyer et al. · Anti-Cancer Drugs · 1999 · 61 citations

, , +17

Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract

William S. Roberts, Mitchel S. Hoffman, John J. Kavanagh et al. · Gynecologic Oncology · 1991 · 52 citations

, , +17

The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered

David M. Gershenson, Michele F. Mitchell, Neely Atkinson et al. · Gynecologic Oncology · 1992 · 48 citations

, , +11

Complete Remission of Refractory Gestational Trophoblastic Disease with Brain Metastases Treated with Multicycle Ifosfamide, Carboplatin, and Etoposide (ICE) and Stem Cell Rescue

Koen van Besien, Claire F. Verschraegen, Rakesh Mehra et al. · Gynecologic Oncology · 1997 · 38 citations

, , +13

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

Claire F. Verschraegen, John J. Kavanagh, Evelyne M. Loyer et al. · Cancer · 2001 · 24 citations

, , +17

1–5 of 7